University Hospital Leuven (UZ) / Universitaire ziekenhuizen Leuven

Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes (2021) Polhemus A, Ortiz LD, Brittain G, Chynkiamis N, Salis F, Gaßner H, Gross M, et al. Journal article, Review article Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) Escala-Garcia M, Canisius S, Keeman R, Beesley J, Anton-Culver H, Arndt V, Augustinsson A, et al. Journal article Obstructed defaecation syndrome: European consensus guidelines on the surgical management (2021) Picciariello A, O'Connell PR, Hahnloser D, Gallo G, Munoz-Duyos A, Schwandner O, Sileri P, et al. Journal article ECCO Topical Review: Refractory Inflammatory Bowel Disease (2021) Raine T, Verstockt B, Kopylov U, Karmiris K, Goldberg R, Atreya R, Burisch J, et al. Journal article, Review article PHENOCOPIESOF CLINICALLY DIAGNOSED ARPKD REVEALED IN CHILDREN (2021) Halawi A, Burgmaier K, Buescher A, Dursun I, Galiano M, Gessner M, Gokce I, et al. Conference contribution Endoscopic tissue sampling - Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2021) Pouw RE, Barret M, Biermann K, Bisschops R, Czako L, Gecse KB, De Hertogh G, et al. Journal article Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer (2021) Quinn MC, McCue K, Shi W, Johnatty SE, Beesley J, Civitarese A, O'Mara TA, et al. Journal article Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies (2021) Espinosa-Ortega F, Holmqvist M, Lodin K, Dastmalchi M, Danieli MG, Venkovsky J, Knitza J, et al. Conference contribution Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) Park HA, Neumeyer S, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, et al. Journal article Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival (2021) Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, et al. Journal article